{"id":"1168016f-87f8-408d-9843-cbb596193a5f","companyId":"366635c3-c5c3-4b1f-bdb3-f4ce77157a22","modelName":"Remebot","slug":"remebot-neurosurgical","description":"China's first NMPA-approved neurosurgical robot (Class III, 2018). Features a six-axis robotic arm with CT/MRI-compatible visual imaging system, AI-based image identification, and 0.5mm positioning precision guided by an independent optical navigation system. Used for brain biopsy, hematoma drainage, and deep brain stimulation electrode implantation across 300+ hospitals","formFactor":"surgical","industryVertical":"healthcare","environment":"indoor","maturityStage":"production","lifecycleState":"active","supersededByModelId":null,"specs":{"procedures":"biopsy, hematoma drainage, DBS electrode placement","clearance_body":"NMPA","procedure_types":"biopsy, hematoma drainage, DBS electrode placement","regulatory_approval":"NMPA 2018"},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.remebot.com.cn/","label":"Remebot Neurosurgical Robot | Beijing Baihui Weikang Technology","title":"Remebot Neurosurgical Robot | Beijing Baihui Weikang Technology","mediaType":"article"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"Form factor","value":"surgical"},{"label":"Regulatory approval","value":"NMPA 2018"},{"label":"Procedures","value":"biopsy, hematoma drainage, DBS electrode placement"},{"label":"Targeting precision","value":"sub-millimeter"}],"createdAt":"2026-06-27T21:36:10.184Z","updatedAt":"2026-08-04T01:04:15.071Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"jsonLd":{"@context":"https://schema.org","@type":"Product","@id":"https://registry.deploy.report/models/remebot-neurosurgical","url":"https://registry.deploy.report/models/remebot-neurosurgical","name":"Remebot","description":"China's first NMPA-approved neurosurgical robot (Class III, 2018). Features a six-axis robotic arm with CT/MRI-compatible visual imaging system, AI-based image identification, and 0.5mm positioning precision guided by an independent optical navigation system. Used for brain biopsy, hematoma drainage, and deep brain stimulation electrode implantation across 300+ hospitals","identifier":"1168016f-87f8-408d-9843-cbb596193a5f","category":"surgical","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"production","lifecycle_state":"active","architectural_position":{"cohort":"surgical","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":[]}}}